258
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

CD47-Fc fusion proteins as putative immunotherapeutic agents for the treatment of immunological and inflammatory diseases

Viral Logic Systems Technology. WO2007133811

Pages 555-561 | Published online: 08 May 2008
 

Abstract

The human cell-surface molecule CD47 is a widely expressed transmembrane glycoprotein that modulates the activity of neutrophils, macrophages, dendritic cells (DCs) and T cells by interacting via its extracellular domain with several endogenous ligands, including thrombospondin-1, signal regulatory protein (SIRP)-α and SIRP-β2. Homologs of CD47 also exist in certain viruses, helping them to elude host immune responses. Therefore, CD47 and its ligands appear to play important roles in the regulation of immune responses and may serve as targets for development of novel immunotherapeutic agents. Accordingly, this patent application describes soluble recombinant CD47-Fc fusion proteins that are made up of the extracellular domain of native or mutated human CD47 or viral CD47 linked to the Fc portion of human immunoglobulin G. One example of human CD47-Fc is shown to inhibit the production of pro-inflammatory cytokines in human DCs. Moreover, a murine CD47-Fc construct is shown to alleviate inflammation in a mouse model of rheumatoid arthritis. It is thus claimed that CD47-Fc proteins may have potential for the treatment of immune and inflammatory disorders. However, further characterization of the biochemical and biological activities of these reagents will be needed to fully appraise their putative therapeutic utility.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.